Codexis Inc (CDXS)
2.655
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
2.655
0.00 (0.00%)
After-Hours: 20:00
Codexis Free Cash Flow (Quarterly): -10.66M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.66M |
| September 30, 2023 | -16.98M |
| June 30, 2023 | -17.67M |
| March 31, 2023 | -11.75M |
| December 31, 2022 | 4.95M |
| September 30, 2022 | 18.42M |
| June 30, 2022 | -4.122M |
| March 31, 2022 | -16.28M |
| December 31, 2021 | -4.82M |
| September 30, 2021 | -4.196M |
| June 30, 2021 | -10.09M |
| March 31, 2021 | -8.99M |
| December 31, 2020 | -2.98M |
| September 30, 2020 | -4.244M |
| June 30, 2020 | -10.80M |
| March 31, 2020 | -2.186M |
| December 31, 2019 | -4.076M |
| September 30, 2019 | -3.047M |
| June 30, 2019 | -5.871M |
| March 31, 2019 | -3.296M |
| December 31, 2018 | -1.414M |
| September 30, 2018 | -1.835M |
| June 30, 2018 | -9.412M |
| March 31, 2018 | -4.201M |
| December 31, 2017 | 7.384M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.913M |
| June 30, 2017 | -8.408M |
| March 31, 2017 | -3.803M |
| December 31, 2016 | 5.062M |
| September 30, 2016 | -7.523M |
| June 30, 2016 | -0.241M |
| March 31, 2016 | -0.046M |
| December 31, 2015 | 6.245M |
| September 30, 2015 | 0.326M |
| June 30, 2015 | -4.303M |
| March 31, 2015 | -3.90M |
| December 31, 2014 | 4.939M |
| September 30, 2014 | 1.53M |
| June 30, 2014 | -4.024M |
| March 31, 2014 | -2.426M |
| December 31, 2013 | -4.633M |
| September 30, 2013 | -8.339M |
| June 30, 2013 | -7.666M |
| March 31, 2013 | -3.535M |
| December 31, 2012 | -5.038M |
| September 30, 2012 | -3.944M |
| June 30, 2012 | -4.329M |
| March 31, 2012 | -1.514M |
| December 31, 2011 | -5.819M |
| September 30, 2011 | -0.877M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-17.67M
Minimum
Jun 2023
18.42M
Maximum
Sep 2022
-6.073M
Average
-4.82M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| Sutro Biopharma Inc | 12.63M |
| Avidity Biosciences Inc | 15.64M |
| Taysha Gene Therapies Inc | -16.13M |
| Janux Therapeutics Inc | -10.42M |
| Tango Therapeutics Inc | -27.69M |